EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Demographics, Cutaneous Manifestations, and Comorbidities Associated with Progressive Cutaneous Sarcoidosis: A Retrospective Cohort Study

Jonathan Lai, Erik Almazan iD, Thomas Le, Matthew T Taylor, Jihad Alhariri, Shawn G Kwatra iD

Medicines · 12.10.2023 · 10 (10) · 57

DOI: 10.3390/medicines10100057 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Medicines, online erschienen am 12.10.2023. Verfasst von Jonathan Lai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcoidosis is a multisystem granulomatous disease with a wide variety of presentations and clinical courses. Cutaneous manifestations and comorbidities associated with sarcoid prognosis remain understudied.

Methods

An EPIC query was run for patients age 18+ at the Johns Hopkins Hospital with a diagnosis of sarcoidosis of the skin according to the ICD-10-CM code D86.3. Data were obtained from a population-based sample of 240 patients from 2015 to 2020.

Results

A total of 240 patients were included in the cohort study. The mean (SD) age was 43.76 (11.72) years, and 30% of participants were male; 76.25% of patients identified as black, 19.58% as white, and 4.17% as other. The average age of onset in remissive patients was significantly higher than progressive (47 ± 12 vs. 40 ± 10, p = 0.0005); 49% of black patients experienced progressive sarcoid compared to 32.6% of white patients (p = 0.028). Progressive disease was associated with the presence of lupus pernio (aOR = 3.29, 95% CI, 1.60–6.77) and at least one autoimmune comorbidity (aOR 6.831, 95% CI 1.819–11.843).

Conclusions

When controlling for patient demographics, lupus pernio and the presence of at least one autoimmune condition were associated with progressive cutaneous sarcoidosis.

Schlagwörter

Stichwörter der Autor:innen

autoimmunecomorbiditiescutaneous lupus perniodemographicserythema nodosumracial disparitiesretrospective cohortsarcoidsarcoidosistreatment resistant

Autor:innen und Institutionen

  • Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

ORCID-Profile: Erik Almazan, Shawn G Kwatra

Zitieren

APA

Lai, J., Almazan, E., Le, T., Taylor, M. T., Alhariri, J., & Kwatra, S. G. (2023). Demographics, Cutaneous Manifestations, and Comorbidities Associated with Progressive Cutaneous Sarcoidosis: A Retrospective Cohort Study. Medicines, 10(10), 57. https://doi.org/10.3390/medicines10100057

Vancouver

Lai J, Almazan E, Le T, Taylor MT, Alhariri J, Kwatra SG. Demographics, Cutaneous Manifestations, and Comorbidities Associated with Progressive Cutaneous Sarcoidosis: A Retrospective Cohort Study. Medicines. 2023;10(10):57. doi:10.3390/medicines10100057

BibTeX
@article{Lai2023,
  author = {Lai, Jonathan and Almazan, Erik and Le, Thomas and Taylor, Matthew T and Alhariri, Jihad and Kwatra, Shawn G},
  title = {Demographics, Cutaneous Manifestations, and Comorbidities Associated with Progressive Cutaneous Sarcoidosis: A Retrospective Cohort Study},
  journal = {Medicines},
  year = {2023},
  volume = {10},
  number = {10},
  pages = {57},
  doi = {10.3390/medicines10100057}
}
Kostenlos starten →